Testolone Enanthate (RAD-140 Ester)
Testolone enanthate is a purported esterified, injectable prodrug of the SARM testolone (RAD-140), sold on the grey market as a longer-acting alternative to oral RAD-140. It is distinct from the marketed RAD-150 (a benzoate ester also sold as "testolone ester"). There is essentially no published human pharmacology for an enanthate ester of RAD-140.
01 Overview
The SARM RAD-140 (testolone) is a non-steroidal androgen receptor ligand with tissue-selective anabolic activity in preclinical models. "Testolone enanthate" refers to grey-market preparations claimed to attach an enanthate chain to RAD-140 to slow release after injection, mirroring the logic of steroid esters.
Unlike the oral RAD-140, which has at least early human exposure data via the enobosarm-era SARM programmes, an enanthate ester of RAD-140 has no meaningful published clinical or pharmacokinetic characterisation. Whatever anabolic effect it has is inferred from the parent SARM, and purity/identity of underground product is unverified.
02 Mechanism
As an ester prodrug, it is presumed to be cleaved to RAD-140, a non-steroidal selective androgen receptor modulator that activates the androgen receptor with relative selectivity for muscle and bone over prostate.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Anecdotal research use | 10–20 mg/wk | IM | No validated human dosing; figures reflect underground practice for the parent SARM only. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Increased lean massParent RAD-140 increases muscle mass in animal models; no controlled human data for the ester. | Model-dependent | Preclinical | |
| Anabolic activity with partial androgen selectivityRAD-140 shows tissue-selective anabolic effects in preclinical work. | Preclinical | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| HPTA suppressionSARMs including RAD-140 suppress endogenous testosterone; users report reduced natural production. | Moderate | Common | Anecdotal | |
| Hepatic strain / transaminase elevationRAD-140 has been linked to case reports of drug-induced liver injury. | Moderate | Uncommon | Anecdotal |